Literature DB >> 7317332

Local recurrence of choroidal malignant melanoma following enucleation.

R F Sanke, J R Collin, A Garner, R B Packard.   

Abstract

542 cases of choroidal malignant melanoma were reviewed. Local recurrence occurred in only 6 patients (1.11%). Five of the 6 patients had distant metastases when the local recurrence was diagnosed, and the remaining patient also developed metastases after a passage of time. These figures do not support the concept of withholding a primary implant at the time of enucleation.

Entities:  

Mesh:

Year:  1981        PMID: 7317332      PMCID: PMC1039692          DOI: 10.1136/bjo.65.12.846

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  A long term follow-up on malignant melanomas of the choroid based on the Terry and Johns series.

Authors:  J F CHISHOLM
Journal:  Am J Ophthalmol       Date:  1953-01       Impact factor: 5.258

2.  PROGNOSIS IN UVEAL MELANOMA.

Authors:  B Benjamin; J N Cumings; A J Goldsmith; A Sorsby
Journal:  Br J Ophthalmol       Date:  1948-10       Impact factor: 4.638

3.  Orbital extension of Choroidal and ciliary body melanomas.

Authors:  H F Shammas; F C Blodi
Journal:  Arch Ophthalmol       Date:  1977-11

4.  Plastic surgery for the enucleation patient.

Authors:  R E Bartlett
Journal:  Am J Ophthalmol       Date:  1966-01       Impact factor: 5.258

5.  Prognostic factors in choroidal and ciliary body melanomas.

Authors:  H F Shammas; F C Blodi
Journal:  Arch Ophthalmol       Date:  1977-01
  5 in total
  2 in total

1.  Enucleation combined with orbital implants for malignant melanoma of the uvea.

Authors:  J Sassmannshausen; N Bornfeld; A Kluge; W Sauerwein; F Härting; A Wessing
Journal:  Int Ophthalmol       Date:  1989-07       Impact factor: 2.031

2.  Local recurrence of uveal melanoma and concomitant brain metastases associated with an activating telomerase promoter mutation seven years after secondary enucleation.

Authors:  Jacob S Heng; Brittany M Perzia; John H Sinard; Renelle Pointdujour-Lim
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.